Exagen (XGN) Insider Trading & Ownership $4.00 -0.10 (-2.44%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$4.09 +0.09 (+2.28%) As of 01/31/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Exagen (NASDAQ:XGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$145,866.97Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$684,417.44 Get XGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Exagen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address XGN Insider Buying and Selling by Quarter Exagen Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/20/2024Nmsic Co-Investment Fund, L.P.Major ShareholderSell200,000$3.30$660,000.00 11/14/2024John AballiCEOBuy24,305$2.81$68,297.05 5/16/2024John AballiCEOBuy40,401$1.92$77,569.92 3/4/2024Kamal AdawiCFOSell12,784$1.91$24,417.44 (Data available from 1/1/2013 forward) XGN Insider Trading Activity - Frequently Asked Questions Who is on Exagen's Insider Roster? The list of insiders at Exagen includes James L L Tullis, John Aballi, Kamal Adawi, Mark Hazeltine, and Nmsic Co-Investment Fund, L.P.. Learn more on insiders at XGN. What percentage of Exagen stock is owned by insiders? 26.10% of Exagen stock is owned by insiders. Learn more on XGN's insider holdings. Which Exagen insiders have been buying company stock? The following insiders have purchased XGN shares in the last 24 months: James L L Tullis ($519.37), and John Aballi ($145,866.97). How much insider buying is happening at Exagen? Insiders have purchased a total of 64,873 XGN shares in the last 24 months for a total of $146,386.34 bought. Which Exagen insiders have been selling company stock? The following insiders have sold XGN shares in the last 24 months: John Aballi ($59,183.25), Kamal Adawi ($24,417.44), Mark Hazeltine ($15,658.49), and Nmsic Co-Investment Fund, L.P. ($660,000.00). How much insider selling is happening at Exagen? Insiders have sold a total of 252,424 Exagen shares in the last 24 months for a total of $759,259.18 sold. Exagen Key ExecutivesDr. Tina S. Nova Ph.D. (Age 70)Executive Chairman of the Board of Directors Compensation: $65kMr. John Aballi (Age 39)CEO, President & Director Compensation: $558.84k1 recent tradesMr. Kamal Adawi M.S. (Age 45)MBA, CFO & Corporate Secretary Compensation: $483.28kRyan DouglasInvestors Relations OfficerMr. John Wegener (Age 55)Senior Vice President of Sales and Marketing Dr. Andrew L. Concoff FACRM.D., Chief Innovation Officer & Member of Rheumatoid Arthritis Scientific Advisory BoardDr. Michael I. Nerenberg M.D. (Age 69)Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies AIRS Insider Trades LFMD Insider Trades SERA Insider Trades BDSX Insider Trades QIPT Insider Trades PIII Insider Trades TOI Insider Trades ENZ Insider Trades BRTX Insider Trades MRAI Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:XGN) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
